Evidence map›Paper›PMID 31171902›Full record

ReviewInternational journal of medical sciences2019

Circular RNAs: Novel Promising Biomarkers in Ocular Diseases.

Nan Guo, Xiu-Fen Liu, Om Prakash Pant, Dan-Dan Zhou, Ji-Long Hao, Cheng-Wei Lu

Open access · goldAbstract readReview
In one paragraph

Review in International journal of medical sciences, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
3.3field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 64 citations in OpenAlex.

  1. In-depth analysis of retinal RNA transcriptome sequencing in a rat model of hypertensive retinopathy.Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences · 2026
    Article
  2. Journal of the American Heart Association · 2023
    Article
  3. Circ_HIPK3 Inhibits HBiochemical genetics · 2023
    Article
  4. Article
  5. CircMAP3K4 protects human lens epithelial cells from HCell cycle (Georgetown, Tex.) · 2023
    Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Circular RNAs: Novel target of diabetic retinopathy.Reviews in endocrine & metabolic disorders · 2021
    Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. CircRNA Is a Rising Star in Researches of Ocular Diseases.Frontiers in cell and developmental biology · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Nan GuoDepartment of Ophthalmology.
Xiu-Fen LiuDepartment of Ophthalmology.
Om Prakash PantDepartment of Ophthalmology.
Dan-Dan ZhouDepartment of Radiology, The First Hospital of Jilin University, No. 71 of xinmin St., Changchun, Jilin Province, 130021, China.
Ji-Long HaoDepartment of Ophthalmology.
Cheng-Wei LuDepartment of Ophthalmology.
Ophthalmology Associates (United States) · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Circular RNAs (circRNAs) are a novel class of endogenous non-coding RNAs produced by back-splicing. They are found to be expressed in eukaryotic cells and play certain roles in various cellular functions, including fibrosis, cell proliferation, differentiation, apoptosis and angiogenesis. Dysregulated circRNAs are found in several human disorders including, malignancy, vascular, inflammatory as well as nervous diseases. Although, increasing evidence suggests that circRNAs may also contribute in different ocular diseases, the outline of circRNAs in ocular diseases remains obscure. In this review we consider the current state of knowledge regarding the potential role and underlying mechanism of circRNAs in ocular diseases including pterygium, age-related cataract, glaucoma, diabetic retinopathy, retinoblastoma, retinal vascular dysfunction and hyperhomocysteinemia induced ocular diseases, emphasizing that circRNAs could be promising biomarkers for the diagnosis and prognosis evaluation. Future circRNAs-targeted intervention may become a novel therapeutic tool for the treatment of ocular diseases.

Indexed as

BiomarkersEye DiseasesHumansPrognosisRNARNA, CircularRNA, UntranslatedBiomarkersRNARNA, CircularRNA, UntranslatedcircRNAsnon-coding RNAsocular diseases

Identifiers

PMID31171902
PMCPMC6535655
OpenAlexW2922986156

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.